Beck Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Beck Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,835	Closed	-$422K	–	78
2019 Q4	$422K	Buy	+2,835	New	+$389K	0.21%	77
2016 Q1	–	Sell	-17,190	Closed	-$1.94M	–	104
2015 Q4	$1.94M	Sell	17,190 -14,855	-46%	-$1.6M	1.14%	33
2015 Q3	$3.18M	Buy	32,045 +5,041	+19%	+$600K	2.21%	15
2015 Q2	$3.35M	Buy	27,004 +1,260	+5%	+$152K	1.79%	13
2015 Q1	$3.04M	Buy	25,744 +971	+4%	+$110K	1.74%	14
2014 Q4	$2.53M	Buy	24,773 +1,918	+8%	+$187K	1.47%	19
2014 Q3	$2.04M	Buy	22,855 +1,664	+8%	+$144K	1.43%	18
2014 Q2	$1.75M	Sell	21,191 -583	-3%	-$44.6K	1.16%	24
2014 Q1	$1.71M	Sell	21,774 -11,006	-34%	-$859K	1.31%	19
2013 Q4	$2.43M	Buy	+32,780	New	+$2.15M	1.96%	12

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Beck Capital Management's FBT Position: Q1 2020 in Review

Beck Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2020, closing a stake of 2,835 shares — an estimated $422K sold.

Beck Capital Management first reported a position in FBT in Q4 2013 and held it in 10 quarters. The position peaked at $3.35M in Q2 2015. 199 funds tracked by Wall St. Rank hold FBT as of Q1 2020.

Beck Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2020 after selling out during the quarter.
Beck Capital Management sold 2,835 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2020, an estimated $422K.
Beck Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2013 and held it in 10 quarters.
Beck Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.35M in Q2 2015.
199 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2020.

Based on Beck Capital Management's 13F filing for Q1 2020, filed 15 May 2020.